• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment.

作者信息

van der Veldt A A M, Oosting S F, Fehrmann R S N, GeurtsvanKessel C H, van Binnendijk R S, Dingemans A-M C, Smit E F, Hiltermann T J N, Hartog G den, Jalving M, Westphal T T, Bhattacharya A, de Wilt F, Ernst S M, Boerma A, van Zijl L, Rimmelzwaan G F, Kvistborg P, van Els C A C M, Rots N Y, van Baarle D, Haanen J B A G, de Vries E G E

机构信息

Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, Netherlands; Radiology & Nuclear Medicine, Erasmus Medical Centre, Rotterdam, Netherlands.

Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.

出版信息

ESMO Open. 2023 Feb;8(1):100785. doi: 10.1016/j.esmoop.2023.100785. Epub 2023 Jan 10.

DOI:10.1016/j.esmoop.2023.100785
PMID:36764094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9829609/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/9929668/02c68df75c9e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/9929668/02c68df75c9e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/9929668/02c68df75c9e/gr1.jpg

相似文献

1
One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment.实体瘤患者在接受全身性癌症治疗期间接种新冠疫苗后免疫原性和突破性感染的一年期数据。
ESMO Open. 2023 Feb;8(1):100785. doi: 10.1016/j.esmoop.2023.100785. Epub 2023 Jan 10.
2
Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel.最后一剂 COVID-19 疫苗接种时间和完全（加强）接种疫苗的医护人员中的 SARS-CoV-2 突破感染。
J Hosp Infect. 2023 Feb;132:46-51. doi: 10.1016/j.jhin.2022.11.016. Epub 2022 Dec 5.
3
High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough Infection.住院时高抗-CoV2S 抗体水平与 COVID-19 疫苗突破性感染患者的生存改善相关。
Int J Environ Res Public Health. 2022 Nov 24;19(23):15581. doi: 10.3390/ijerph192315581.
4
SARS-CoV-2 breakthrough infections in vaccinated individuals requiring ventilatory support for severe acute respiratory failure.接种疫苗的个体中出现严重急性呼吸衰竭需要通气支持的2019冠状病毒病突破性感染病例。
Intensive Care Med. 2023 Feb;49(2):248-250. doi: 10.1007/s00134-022-06952-2. Epub 2023 Jan 25.
5
Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021.2020 年 12 月至 2021 年 11 月期间，美国接种疫苗的癌症患者突破性 SARS-CoV-2 感染、住院和死亡。
JAMA Oncol. 2022 Jul 1;8(7):1027-1034. doi: 10.1001/jamaoncol.2022.1096.
6
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2.评估免疫功能低下的患者在完全接种 BNT162b2 后突破性感染 COVID-19 疫苗的情况。
J Med Econ. 2021 Jan-Dec;24(1):1248-1260. doi: 10.1080/13696998.2021.2002063.
7
Clinical features and severe outcome predictors of COVID-19 vaccine breakthrough infection among hospitalized patients: results from Egypt severe acute respiratory infections sentinel surveillance, 2021-2022.2021-2022 年埃及严重急性呼吸道感染哨点监测中住院患者 COVID-19 疫苗突破性感染的临床特征和严重结局预测因素：结果。
BMC Infect Dis. 2023 Mar 6;23(1):130. doi: 10.1186/s12879-023-08097-z.
8
The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults.完全接种疫苗的成年人中抗刺突 SARS-CoV-2 抗体水平与突破性 COVID-19 风险之间的关系。
J Infect Dis. 2023 Feb 1;227(3):339-343. doi: 10.1093/infdis/jiac403.
9
Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection.COVID-19 突破性感染后未接种疫苗和接种疫苗者在 3-15 个月后的急性后期症状。
Int J Infect Dis. 2023 Jan;126:10-13. doi: 10.1016/j.ijid.2022.11.009. Epub 2022 Nov 12.
10
Quantitative Analysis of SARS-CoV-2 Antibody Levels in Cancer Patients Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections.免疫接种三剂后和突破性 COVID-19 感染前癌症患者 SARS-CoV-2 抗体水平的定量分析。
Curr Oncol. 2022 Sep 28;29(10):7059-7071. doi: 10.3390/curroncol29100554.

引用本文的文献

1
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy.mRNA-1273 疫苗接种可诱导接受免疫治疗和/或化疗的实体瘤患者产生多功能记忆 CD4 和 CD8 T 细胞应答。
Front Immunol. 2024 Aug 27;15:1447555. doi: 10.3389/fimmu.2024.1447555. eCollection 2024.
2
Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study.加强针接种后的抗体反应对晚期癌症患者 SARS-CoV-2 突破感染和疾病结局的影响：Vax-on-Third 研究的前瞻性分析。
Curr Oncol. 2023 May 17;30(5):5103-5115. doi: 10.3390/curroncol30050386.